ASSOBRAFIR Ciência
https://assobrafirciencia.org/article/doi/10.47066/2177-9333.AC.2019.0002
ASSOBRAFIR Ciência
Artigo Original

Confiabilidade interavaliador e teste-reteste do teste de AVD-Glittre em indivíduos saudáveis

Inter-rater and test-retest reliabilities of the Glittre-ADL test in healthy subjects

Dayane Montemezzo, Anelise Sonza, Aline Andrioni Fernandes, Hellen Fontão Alexandre, Danielle Aparecida Gomes Pereira, Raquel Rodrigues Britto

Downloads: 5
Views: 782

Resumo

Introdução: O teste de AVD-Glittre (TGlittre) é válido para avaliar a capacidade funcional. Entretanto, poucos estudos verificaram suas propriedades de medida. Objetivo: Avaliar a confiabilidade interavaliador e testereteste do TGlittre em indivíduos saudáveis. Métodos: Treze indivíduos saudáveis (8 mulheres; 27,3 ± 3,94 anos) tiveram seu histórico de saúde, atividade física, antropometria e capacidade funcional avaliados. No primeiro dia, o TGlittre foi realizado duas vezes, randomizadamente, por dois avaliadores independentes. No segundo, apenas um TGlittre foi realizado, pelo avaliador 1. As avaliações foram separadas por, no mínimo, 7, e, no máximo, 14 dias. Análise Estatística: Foram utilizados, o coeficiente de correlação intraclasse (CCI) e o intervalo de confiança de 95% (IC95%) das médias entre os dois TGlittre (confiabilidades interavaliador e teste-reteste). Resultados: A média de tempo do TGlittre foi de 2,66 ± 0,26 minutos, no dia 1; 2,45 ± 0,22 minutos, no dia 2. CCI de 0,83 (IC95%: 0,52-0,94; p<0,001) e 0,88 (IC95%: 0,65-0,96; p <0,001) foram obtidos para as confiabilidades interavaliador e teste-reteste, respectivamente. Conclusão: O TGlittre demonstrou adequada confiabilidade, para avaliar a capacidade funcional de indivíduos saudáveis.

Palavras-chave

Reprodutibilidade dos Testes; Atividades Cotidianas; Participantes Saudáveis.

Abstract

Background: The Glittre ADL-test (TGlittre) can assess functional capacity. However, few studies verified its measurement properties. Aim: To evaluate inter-rater and test-retest reliabilities of the TGlittre in healthy subjects. Methods: Thirteen healthy subjects (8 women; 27.3 ± 3.94 years) were assessed for health history, physical activity, anthropometry and functional capacity. On the first assessment, the TGlittre was randomly performed twice and independently by two different raters (rater 1 and rater 2). On the second assessment, the TGlittre was performed only once, by the rater 1. The assessments were separated by at least seven days and a maximum 14 days apart. Statistical analyses: the intraclass correlation coefficient (ICC) and its 95% confidence interval (95%CI) of the mean differences between two TGlittre were used (inter-rater and test-retest). Results: the mean time spent in the TGlittre was 2.66 ± 0.26 minutes on day 1 and 2.45 ± 0.22 minutes on day 2. An ICC of 0.83 (95%CI: 0.52-0.94; p<0.001) and 0.88 (95%CI: 0.65-0.96; p <0.001) was obtained for inter-rater and test-retest reliabilities, respectively. Conclusion: The TGlittre demonstrated adequate reliabilities to assess the functional capacity of healthy individuals.

Keywords

Reproducibility of results; Activities of daily living; Healthy participants

Referências

1.Leidy NK. Using functional status to assess treatment outcomes. Chest. 1994 Dec;106(6):1645-6. doi: 10.1378/chest.106.6.1645.

2.American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7. doi: 10.1164/ajrccm.166.1.at1102.

3.Skumlien S, Hagelund T, Bjørtuft O, Ryg MS. A field test of functional status as performance of activities of daily living in COPD patients. Respir Med. 2006 Feb;100(2):316-23. doi: 10.1016/j.rmed.2005.04.022. Epub 2005 Jun 6.

4.Karloh M, Palú M, Mayer AF. Métodos de avaliação da capacidade funcional em pacientes com DPOC. ConScientiae Saúde. 2014;13(4):633-649. DOI: https://doi.org/10.5585/conssaude. v13n4.4830.

5.Janaudis-Ferreira T, Beauchamp MK, Robles PG, Goldstein RS, Brooks D. Measurement of activities of daily living in patients with COPD: a systematic review. Chest. 2014 Feb;145(2):253-271. doi: 10.1378/chest.13-0016.

6.Bui KL, Nyberg A, Maltais F, Saey D. Functional Tests in Chronic Obstructive Pulmonary Disease, Part 1: Clinical Relevance and Links to the International Classification of Functioning, Disability, and Health. Ann Am Thorac Soc. 2017 May;14(5):778-784. doi: 10.1513/AnnalsATS.201609-733AS.

7.Bui KL, Nyberg A, Maltais F, Saey D. Functional Tests in Chronic Obstructive Pulmonary Disease, Part 2: Measurement Properties. Ann Am Thorac Soc. 2017 May;14(5):785-794. doi: 10.1513/AnnalsATS.201609-734AS.

8.Gulart AA, Munari AB, Klein SR, Santos da Silveira L, Mayer AF. The Glittre-ADL Test Cut-Off Point to Discriminate Abnormal Functional Capacity in Patients with COPD. COPD. 2018 Feb;15(1):73-78. doi: 10.1080/15412555.2017.1369505.

9.Reis CMD, Karloh M, Fonseca FR, Biscaro RRM, Mazo GZ, Mayer AF. Functional capacity measurement: reference equations for the Glittre Activities of Daily Living test. J Bras Pneumol. 2018 Sep-Oct;44(5):370-377. doi: 10.1590/S1806-37562017000000118. Epub 2018 Jul 16.

10.Martins R, Assumpção MS, Bobbio TG, Mayer AF, Schivinski C. The validity and reliability of the ADL-Glittre test for children. Physiother Theory Pract. 2019 Aug;35(8):773-780. doi: 10.1080/09593985.2018.1457747. Epub 2018 Apr 16.

11.Monteiro F, Ponce DA, Silva H, Carrilho AF, Pitta F. Validity and Reproducibility of the Glittre ADL-Test in Obese and Post-Bariatric Surgery Patients. Obes Surg. 2017 Jan;27(1):110-114. doi: 10.1007/s11695-016-2244-7.

12.Fernandes-Andrade AA, Britto RR, Soares DCM, Velloso M, Pereira DAG. Evaluation of the Glittre-ADL test as an instrument for classifying functional capacity of individuals with cardiovascular diseases. Braz J Phys Ther. Sep-Oct 2017;21(5):321-328. doi: 10.1016/j.bjpt.2017.06.001. Epub 2017 Jul 3.

13.Dal Lago P, Reinaldo GP, de Araujo CL, Schneider B, Menezes V, et al. Applicability and reproducibility of the Glittre-ADL test and association with the muscle thickness of pectoralis major and latissimus dorsi in patients with idiopathic pulmonary fibrosis. ASSOBRAFIR Ciência. 2018 Out;9(Supl 1):115. Abstract.

14.dos Reis CM, Da Silva TC, Karloh M, De Araújo CLP, Gulart AA, Mayer AF. Performance of healthy adult subjects in Glittre ADL-test. Fisioter Pesqui. 2015 Jan-Mar;22(1):41-47. doi: https://doi.org/10.590/1809-2950/13125722012015. Portuguese.

15.Corrêa KS, Karloh M, Martins LQ, dos Santos K, Mayer AF. Can the Glittre ADL test differentiate the functional capacity of COPD patients from that of healthy subjects? Rev Bras Fisioter. 2011 NovDec;15(6):467-73. Epub Nov 21, 2011. doi: https://doi.org/10.1590/S1413-35552011005000034.

16.Vardar-Yagli N, Erdem F, Inal-Ince D, Coplu L, Kutukcu EC, Saglam M, et al. Determinants of the Glittre ADL test in patients with chronic obstructive pulmonary disease. Eur Respir J. 2014;44(Suppl 58).

17.Jette AM, Tao W, Norweg A, Haley S. Interpreting rehabilitation outcome measurements. J Rehabil Med. 2007 Oct;39(8):585-90. doi: 10.2340/16501977-0119.

18.Portney LG,Watkins MP. Foundations of clinical research: Applications to practice. 3rd ed. New Jersey: Prentice Hall; 2015.

19.American Thoracic Society, American College of Chest P. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77. doi: 10.1164/rccm.167.2.211.

20.Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011 Jul;43(7):1334-59. doi: 10.1249/MSS.0b013e318213fefb.

21.Souza AC, Alexandre NMC, Guirardello EB. Psychometric properties in instruments evaluation of reliability and validity. Epidemiol Serv Saude. 2017 Jul-Sep;26(3):649-59. doi: 10.5123/S1679-49742017000300022.

22.Souza GF, Moreira GL, Tufanin A, Gazzotti MR, Castro AA, Jardim JR, et al. Physiological Requirements to Perform the Glittre Activities of Daily Living Test by Subjects With Mild-to-Severe COPD. Respir Care. 2017 Aug;62(8):1049-1057. doi: 10.4187/respcare.05113. Epub 2017 May 30.

5f6cfab30e8825c66397b914 assobrafir Articles
Links & Downloads

ASSOBRAFIR Ciência

Share this page
Page Sections